Fed. Circ. Affirms For Promega In DNA Analysis Patent Row

Law360, New York (March 10, 2014, 8:10 PM EDT) -- The Federal Circuit handed a win to biotechnology company Promega Corp. on Monday when it affirmed a lower court’s finding that claims in a patent asserted by Life Technologies Corp. over a method for fluorescence-based DNA analysis were invalid.

In a one-word order, the appeals court affirmed a June ruling by U.S. Circuit Judge Richard A. Posner, which found that Life Technologies' asserted claims in U.S. Patent Number RE43,096 were invalid due to prior art found in an expired patent owned by the California Institute of...
To view the full article, register now.